Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| HX002755-01A2 | Other Grant/Funding Number | U.S. Department of Veterans Affairs |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Posttraumatic Stress Disorder (PTSD) is common among Veterans and results in poor psychological functioning, quality of life, and physical health. This includes having disproportionately high rates of obesity, in part due to PTSD symptoms interfering with physical activity and healthy diet. Unfortunately, Veterans with PTSD have poorer weight loss outcomes than those without PTSD in VA's existing weight management program, MOVE!. Based on pilot work, it appears that a weight management program that augments standard PTSD care and targets PTSD-related barriers to weight loss improves weight and PTSD symptoms. Whether it improves these issues more than standard VA care is in need of study, which is the focus of the proposed research. The proposed study also seeks to understand factors that would interfere with and facilitate implementing the program in VA if it is effective. This Veteran-centered, tailored weight loss program may efficiently benefit both physical and mental health of Veterans with PTSD, addressing standard care limitations.
Background: Post-traumatic stress disorder (PTSD), prevalent among Veterans, puts Veterans at increased risk for obesity and related conditions. Veterans with PTSD lose less weight in VA's MOVE! weight management program, due to PTSD symptoms that interfere with activity and healthy diet. In addition, many Veterans who receive evidence-based PTSD treatment remain symptomatic. A behavioral weight loss program that augments standard PTSD care and targets PTSD-related weight loss barriers called MOVE!+UP was piloted and iteratively refined among 44 overweight Veterans with PTSD. The fully developed MOVE!+UP is led by a psychologist and a Veteran peer support counselor, who provide complementary expertise. It includes 16 group sessions with 90 minutes of general weight loss support, coupled with Cognitive Behavior Therapy skills to address PTSD-specific barriers. Each session also includes a 30-minute community walk to address hypervigilance-based activity barriers and enhance classroom-based learning. Veterans receive two individual dietician visits, and counseling calls as needed. The cohort receiving the final MOVE!+UP package reported high satisfaction and had better weight loss outcomes than Veterans with PTSD in the general MOVE! program. They also reported substantial PTSD symptom reduction. Treatment targets like eating behaviors, activity, and insomnia also improved. MOVE!+UP effectiveness must be tested in a randomized trial.
Significance/Impact: MOVE!+UP is timely and efficient, simultaneously addressing physical and mental health of a priority Veteran group. MOVE!+UP is positioned to address HSR&D priorities by promoting mental health and improving PTSD symptoms, access to care, and whole health. This study is aligned with HSR&D and ORD methodological priorities by using a hybrid type 1 trial. This study's cost and utilization analyses, and systematic identification of implementation barriers and facilitators, would place effectiveness findings in context and facilitate rapid translation to the field if MOVE!+UP is effective. This study will also provide insights about ways that general MOVE! and PTSD care can be enhanced to improve reach and effectiveness.
Innovation: MOVE!+UP is the first weight loss program designed to address obesity in Veterans with PTSD.
Specific Aims: This study proposes to enroll Veterans with PTSD who are classified as overweight or with obesity and who are engaged in PTSD care. They will be randomized to usual care enhanced with MOVE! (control) or usual care enhanced with MOVE!+UP (intervention), and is guided by three aims: 1) Test whether intervention participants have greater 6-month weight loss (primary outcome), and 6- and 12-month PTSD symptom reduction and 12-month weight loss (secondary exploratory outcomes), relative to controls; 2) Assess whether compared to control, intervention participants have greater improvements on 6-month treatment targets: physical activity, eating behavior, insomnia, depression, and social support; 3) Estimate intervention and control condition costs and utilization, and identify MOVE!+UP implementation barriers and facilitators, to contextualize Aim 1 and inform future implementation.
Methodology: Hybrid type 1 trial with 164 Veterans with PTSD who are classified as overweight or with obesity and are currently enrolled in PTSD care.
Implementation/Next Steps: This hybrid type 1 trial will provide data needed to prepare a MOVE!+UP implementation package for broader VA implementation if MOVE!+UP is effective. If it is not effective, Aims 2 and 3 will help understand how overweight Veterans with PTSD could be better supported in the future. Implementation activities would be coordinated with existing local, VISN, and national operational partners.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MOVE!+UP (intervention) | Experimental | usual care enhanced with MOVE!+UP (intervention) |
|
| MOVE! (control condition) | Active Comparator | usual care enhanced with MOVE! (control condition) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MOVE!+UP | Behavioral | behavioral weight management intervention developed for Veterans with PTSD |
|
| Measure | Description | Time Frame |
|---|---|---|
| Weight (Pounds) Change From Baseline to 6 Months Post-baseline | This study's primary aims is to test whether intervention participants have greater 6-month weight loss, relative to controls. | baseline and 6 months post-baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Weight (Pounds) Change From Baseline to 12 Months Post-baseline | Test whether intervention participants have greater long-term (12-month) weight loss, relative to controls. | baseline and 12 months post-baseline |
| PTSD Symptom Severity on the PTSD Checklist for DSM-5 Change From Baseline to 6 Months Post-baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Insomnia Measured With the Insomnia Severity Index Change From Baseline to 6 Months Post-baseline | Assess whether compared to control, intervention participants have greater improvements on 6-month insomnia severity. Total scores range 0 - 28, with higher scores indicating more acute symptoms of insomnia. | baseline and 6 months post-baseline |
Inclusion Criteria:
Exclusion Criteria:
Not fluent in English, severe hearing loss, no phone access
Current MOVE! participation
Current pregnancy
Based on clinical judgment, would be unable to participate because of:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Katherine D Hoerster, PhD MPH BA | VA Puget Sound Health Care System Seattle Division, Seattle, WA | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle | Washington | 98108-1532 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34144246 | Result | Hoerster KD, Tanksley L, Sulayman N, Bondzie J, Brier M, Damschroder L, Coggeshall S, Houseknecht D, Hunter-Merrill R, Monty G, Saelens BE, Sayre G, Simpson T, Wong E, Nelson K. Testing a tailored weight management program for veterans with PTSD: The MOVE! + UP randomized controlled trial. Contemp Clin Trials. 2021 Aug;107:106487. doi: 10.1016/j.cct.2021.106487. Epub 2021 Jun 16. | |
| 41893847 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We randomized 174 enrolled participants to MOVE! (control) or MOVE!+UP (intervention) in a 1:1 ratio within each recruitment cohort, using a permuted block design, with varying block sizes (2 or 4). People doing data collection and analysis remained masked until after 12-month data collection.
From 10/1/2020-2/28/2024, we sent recruitment materials to cohorts of randomly selected veterans meeting several VHA electronic health record (EHR)-based criteria. Potentially eligible patients were also identified from self or clinician referral. We then used manual chart review to determine whether patients met additional criteria. We then further phone-screened participants for self-reported eligibility. To determine final eligibility, study staff conducted a video visit to assess weight/BMI.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Active Comparator: MOVE! (Control Condition) | MOVE! is the standard VA weight management intervention |
| FG001 | Experimental: MOVE!+UP (Intervention) | MOVE!+UP is a novel behavioral weight management intervention developed for Veterans with PTSD |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Active Comparator: MOVE! | VA's standard weight management program |
| BG001 | Experimental Condition: MOVE!+UP | Behavioral weight management program for Veterans with PTSD |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Weight (Pounds) Change From Baseline to 6 Months Post-baseline | This study's primary aims is to test whether intervention participants have greater 6-month weight loss, relative to controls. | Posted | Mean | Standard Deviation | pounds | baseline and 6 months post-baseline |
|
Enrollment through 12-month follow-up
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Active Comparator: MOVE! | VA's standard weight management program | 2 |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Blood Clot | Cardiac disorders | Systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Joint/Limb/Scar Pain | Musculoskeletal and connective tissue disorders | Systematic Assessment |
Prompted by the COVID-19 pandemic, we modified our procedures from previously-planned in-person assessments to hold visits via video, which at times impeded visualization of participants' weights. Also due to the pandemic, we modified our intervention (and control groups) to be delivered by video, which may have affected their effectiveness; however, prior work has shown that this is unlikely to be the case.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Katherine Hoerster, PhD, MPH (Principal Investigator) | VA Puget Sound Health Care System, Seattle Division | 206-277-4203 | Katherine.Hoerster@va.gov |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jun 26, 2025 | Mar 17, 2026 | Prot_SAP_001.pdf |
| ICF | No | No | Yes | Informed Consent Form | Oct 13, 2023 | Mar 24, 2026 | ICF_002.pdf |
Not provided
| ID | Term |
|---|---|
| D013313 | Stress Disorders, Post-Traumatic |
| D050177 | Overweight |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |
| D044343 | Overnutrition |
Not provided
Not provided
This is a hybrid type 1 trial with Veterans with PTSD who are classified as overweight or with obesity, and who are currently enrolled in PTSD care. Participants will be randomized to usual care enhanced with MOVE! (control) or usual care enhanced with MOVE!+UP (intervention).
Not provided
Not provided
Outcomes assessors will not know the treatment assignment. Because this is a behavioral intervention, with supervision provided by the lead investigator, the participants, care providers, and investigators will not be blinded.
| MOVE! | Behavioral | standard VA weight management intervention |
|
Assess whether compared to control, intervention participants have greater improvements on 6-month PTSD symptom severity. Total scores range 0 - 80, where higher scores are indicative of greater severity. |
| baseline and 6 months post-baseline |
| PTSD Symptom Severity on the PTSD Checklist for DSM-5 Change From Baseline to 12 Months Post-baseline | Assess whether compared to control, intervention participants have greater improvements on 12-month PTSD symptom severity. Total scores range 0 - 80, where higher scores are indicative of greater severity. | baseline and 12 months post-baseline |
| Average Daily Light, Moderate, and Vigorous Physical Activity Measured With Accelerometers (Change From Baseline to 6 Months Post-baseline) |
Assess whether compared to control, intervention participants have greater improvements on 6-month accelerometry-based light, moderate, and vigorous physical activity. This variable combines all forms of physical activity into a single measure. |
| baseline and 6 months post-baseline |
| Average Daily Moderate and Vigorous Physical Activity Measured With Accelerometers (Change From Baseline to 6-months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month accelerometry-based moderate and vigorous physical activity. This measure combines only moderate and vigorous activity because this is the higher activity threshold to achieve and more closely aligns with the type of activity recommended in standard activity recommendations. | baseline and 6 months post-baseline |
| Depression Severity Measured With the Patient Health Questionnaire, 8-item Version (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month depression symptoms. Total scores range 0 - 24 where higher scores indicate greater depression severity. | baseline and 6 months post-baseline |
| Internalized Weight Bias Measured With "Modified Weight Bias Internalization Scale" (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month internalized weight bias. The measure was changed only slightly to add one item reflecting positive body image: "I love my shape and size." Scores for items were summed and then averaged, with those for positive body image reverse-scored. Scores ranged from 1-7, with higher scores representing worse weight bias internalization. | baseline and 6 months post-baseline |
| Eating Habits Measured With "PACE" Eating Habits Measure (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month eating habits. Scores for items were summed and then averaged, with a summary score range from 0-4, with higher scores indicating worse eating habits. | baseline and 6 months post-baseline |
| Social Support for Physical Activity (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month social support for physical activity. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating better support. | baseline and 6 months post-baseline |
| Social Support for Healthy Eating (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month social support for healthy eating. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating better support. | baseline and 6 months post-baseline |
| Discouragement for Healthy Eating (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month discouragement for healthy eating. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating greater discouragement. | baseline and 6 months post-baseline |
| Discouragement for Physical Activity (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month discouragement for physical activity. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating greater discouragement. | baseline and 6 months post-baseline |
| Night Eating Measured With the Night Eating Questionnaire (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month night eating symptoms. Scores for items were summed. The overall scale score ranged from 0-24, with higher scores indicating greater night eating. | baseline and 6 months post-baseline |
| Emotional Eating Measured With the Emotional Overeating Questionnaire (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month emotional eating. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating greater emotional eating. | baseline and 6 months post-baseline |
| Diet Quality Measured With "Starting the Conversation" (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month diet quality. Scores for items were summed. The overall score for the scale ranged from 0-16, with higher scores indicating worse diet quality. | baseline and 6 months post-baseline |
| Binge Eating (Yes vs. no at 6 Months Post-baseline) Measured Using an Adapted Patient Health Questionnaire for DSM 5 Criteria | Assess whether compared to control, intervention participants have lower prevalence of engaging in binge eating at 6 months post-baseline. Those reporting current binge eating behavior (with or without engaging in purging) were designated as yes, binge eating, and the outcome prevalence is presented for those who do engage in binge eating. Those who did not endorse binge eating behavior were designated as no. | 6 months post-baseline |
| Derived |
| Hoerster KD, Sulayman N, Hunter-Merrill R, Coggeshall S, Tanksley L, Brier M, Donovan L, Fennell T, Gray K, Evans DH, Rosendahl K, Saelens BE, Simpson T, Nelson KM. Enhanced Weight Management Program for Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2026 Mar 2;9(3):e261904. doi: 10.1001/jamanetworkopen.2026.1904. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Self-reported race, regardless of Hispanic/Latino ethnicity | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Self-reported Hispanic/Latino ethnicity | Count of Participants | Participants |
|
| Household annual family income | Count of Participants | Participants |
|
| Body Mass Index | Mean | Standard Deviation | kg/m^2 |
|
| Units |
|---|
| Counts |
|---|
| Participants |
|
|
|
| Secondary | Weight (Pounds) Change From Baseline to 12 Months Post-baseline | Test whether intervention participants have greater long-term (12-month) weight loss, relative to controls. | Posted | Mean | Standard Deviation | pounds | baseline and 12 months post-baseline |
|
|
|
|
| Secondary | PTSD Symptom Severity on the PTSD Checklist for DSM-5 Change From Baseline to 6 Months Post-baseline | Assess whether compared to control, intervention participants have greater improvements on 6-month PTSD symptom severity. Total scores range 0 - 80, where higher scores are indicative of greater severity. | Posted | Mean | Standard Deviation | score on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Insomnia Measured With the Insomnia Severity Index Change From Baseline to 6 Months Post-baseline | Assess whether compared to control, intervention participants have greater improvements on 6-month insomnia severity. Total scores range 0 - 28, with higher scores indicating more acute symptoms of insomnia. | Posted | Mean | Standard Deviation | score on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Average Daily Light, Moderate, and Vigorous Physical Activity Measured With Accelerometers (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month accelerometry-based light, moderate, and vigorous physical activity. This variable combines all forms of physical activity into a single measure. | Posted | Mean | Standard Deviation | minutes | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Average Daily Moderate and Vigorous Physical Activity Measured With Accelerometers (Change From Baseline to 6-months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month accelerometry-based moderate and vigorous physical activity. This measure combines only moderate and vigorous activity because this is the higher activity threshold to achieve and more closely aligns with the type of activity recommended in standard activity recommendations. | Posted | Mean | Standard Deviation | minutes | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Depression Severity Measured With the Patient Health Questionnaire, 8-item Version (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month depression symptoms. Total scores range 0 - 24 where higher scores indicate greater depression severity. | Posted | Mean | Standard Deviation | score on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Internalized Weight Bias Measured With "Modified Weight Bias Internalization Scale" (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month internalized weight bias. The measure was changed only slightly to add one item reflecting positive body image: "I love my shape and size." Scores for items were summed and then averaged, with those for positive body image reverse-scored. Scores ranged from 1-7, with higher scores representing worse weight bias internalization. | Posted | Mean | Standard Deviation | score | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Eating Habits Measured With "PACE" Eating Habits Measure (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month eating habits. Scores for items were summed and then averaged, with a summary score range from 0-4, with higher scores indicating worse eating habits. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Social Support for Physical Activity (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month social support for physical activity. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating better support. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Social Support for Healthy Eating (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month social support for healthy eating. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating better support. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Discouragement for Healthy Eating (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month discouragement for healthy eating. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating greater discouragement. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Discouragement for Physical Activity (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month discouragement for physical activity. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating greater discouragement. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Night Eating Measured With the Night Eating Questionnaire (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month night eating symptoms. Scores for items were summed. The overall scale score ranged from 0-24, with higher scores indicating greater night eating. | Posted | Mean | Standard Deviation | score | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Emotional Eating Measured With the Emotional Overeating Questionnaire (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month emotional eating. Scores for items were summed and then averaged. Scores ranged from 0-4, with higher scores indicating greater emotional eating. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Diet Quality Measured With "Starting the Conversation" (Change From Baseline to 6 Months Post-baseline) | Assess whether compared to control, intervention participants have greater improvements on 6-month diet quality. Scores for items were summed. The overall score for the scale ranged from 0-16, with higher scores indicating worse diet quality. | Posted | Mean | Standard Deviation | scores on a scale | baseline and 6 months post-baseline |
|
|
|
|
| Other Pre-specified | Binge Eating (Yes vs. no at 6 Months Post-baseline) Measured Using an Adapted Patient Health Questionnaire for DSM 5 Criteria | Assess whether compared to control, intervention participants have lower prevalence of engaging in binge eating at 6 months post-baseline. Those reporting current binge eating behavior (with or without engaging in purging) were designated as yes, binge eating, and the outcome prevalence is presented for those who do engage in binge eating. Those who did not endorse binge eating behavior were designated as no. | Posted | Count of Participants | Participants | 6 months post-baseline |
|
|
|
|
| Secondary | PTSD Symptom Severity on the PTSD Checklist for DSM-5 Change From Baseline to 12 Months Post-baseline | Assess whether compared to control, intervention participants have greater improvements on 12-month PTSD symptom severity. Total scores range 0 - 80, where higher scores are indicative of greater severity. | Posted | Mean | Standard Deviation | score on a scale | baseline and 12 months post-baseline |
|
|
|
|
| 89 |
| 5 |
| 89 |
| 60 |
| 89 |
| EG001 | Experimental Condition: MOVE!+UP | Behavioral weight management program for Veterans with PTSD | 0 | 85 | 5 | 85 | 60 | 85 |
| Stroke (death) | Cardiac disorders | Systematic Assessment |
|
| Syncope | Cardiac disorders | Systematic Assessment |
|
| Pacreatitis | Gastrointestinal disorders | Systematic Assessment |
|
| Sepsis | Infections and infestations | Systematic Assessment |
|
| Diabetes | Metabolism and nutrition disorders | Systematic Assessment |
|
| Lymphoma | Blood and lymphatic system disorders | Systematic Assessment |
|
| Seizures | Nervous system disorders | Systematic Assessment |
|
| Diabetes (death) | Metabolism and nutrition disorders | Systematic Assessment |
|
| Rheumatoid Arthritis | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Neuropathy | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Fall/injury | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Blood Pressure | Cardiac disorders | Systematic Assessment |
|
| High Cholesterol | Cardiac disorders | Systematic Assessment |
|
| Chest Pain/Pacemaker | Cardiac disorders | Systematic Assessment |
|
| Blood Clot | Cardiac disorders | Systematic Assessment |
|
| Congestive Heart Failure | Cardiac disorders | Systematic Assessment |
|
| Surgery | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Melanoma/Carcinoma | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Injury | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Infection | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Colon | Gastrointestinal disorders | Systematic Assessment |
|
| Stomach Pain/Distress | Gastrointestinal disorders | Systematic Assessment |
|
| Surgery | Gastrointestinal disorders | Systematic Assessment |
|
| Esophagus | Gastrointestinal disorders | Systematic Assessment |
|
| Pacreatitis | Gastrointestinal disorders | Systematic Assessment |
|
| Liver/Cirrhosis | Gastrointestinal disorders | Systematic Assessment |
|
| Crohn's Disease | Gastrointestinal disorders | Systematic Assessment |
|
| Blood Clot | Blood and lymphatic system disorders | Systematic Assessment |
|
| Metabolic Syndrome | Metabolism and nutrition disorders | Systematic Assessment |
|
| Diabetes | Metabolism and nutrition disorders | Systematic Assessment |
|
| Hematoma | Nervous system disorders | Systematic Assessment |
|
| Pain/Migraines/Dizziness | Nervous system disorders | Systematic Assessment |
|
| Tumor | Nervous system disorders | Systematic Assessment |
|
| Parkinsons | Nervous system disorders | Systematic Assessment |
|
| Circulatory | Nervous system disorders | Systematic Assessment |
|
| Vision/Memory Loss | Nervous system disorders | Systematic Assessment |
|
| Head Injury/Concussion | Nervous system disorders | Systematic Assessment |
|
| Stroke/Related Conditions | Nervous system disorders | Systematic Assessment |
|
| Pain/Bleeding | Reproductive system and breast disorders | Systematic Assessment |
|
| Surgery | Reproductive system and breast disorders | Systematic Assessment |
|
| Birth Control | Reproductive system and breast disorders | Systematic Assessment |
|
| Endomitriosis | Reproductive system and breast disorders | Systematic Assessment |
|
| Surgery | Eye disorders | Systematic Assessment |
|
| Infection/Disease | Eye disorders | Systematic Assessment |
|
| Injury | Eye disorders | Systematic Assessment |
|
| Infection | Ear and labyrinth disorders | Systematic Assessment |
|
| Tinnitus/Hearing Loss | Ear and labyrinth disorders | Systematic Assessment |
|
| Surgery | Ear and labyrinth disorders | Systematic Assessment |
|
| Suicidal Ideation | Psychiatric disorders | Systematic Assessment |
|
| Withdrawal Symptoms | Psychiatric disorders | Systematic Assessment |
|
| Eating Disorder | Psychiatric disorders | Systematic Assessment |
|
| Mood Affect | Psychiatric disorders | Systematic Assessment |
|
| Increased PTSD Symptoms | Psychiatric disorders | Systematic Assessment |
|
| Increased Mental Health Symptoms | Psychiatric disorders | Systematic Assessment |
|
| New Mental Health Diagnosis | Psychiatric disorders | Systematic Assessment |
|
| Respiratory Distress | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| COVID-19 | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Asthma | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Infection | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Nodules | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Cancer | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Kidney Stones | Renal and urinary disorders | Systematic Assessment |
|
| Blood Clot | Renal and urinary disorders | Systematic Assessment |
|
| Infection | Renal and urinary disorders | Systematic Assessment |
|
| Incontinence | Renal and urinary disorders | Systematic Assessment |
|
| Cancer | Renal and urinary disorders | Systematic Assessment |
|
| Prostate | Renal and urinary disorders | Systematic Assessment |
|
Not provided
Not provided
Not provided
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |